A deep learning framework (DLF) to identify clinical predictors of disease progression and mortality in metastatic castration-resistant prostate cancer (mCRPC) patients treated with docetaxel/prednisone (DP)

TopaziumLeave a comment

Background: Treatment with DP improves survival in mCRCP but is associated with significant toxicity. The question remains as to whether the improved survival is worth the toxicity risk. In this study, we have investigated the ability of a DLF to identify those patients on which treatment with DP is likely to be beneficial. Methods: The…